Financials

  • Market Capitalization 3.29 B
  • Employee 370
  • Founded 2016
  • CEO N/A
  • Website www.tarsusrx.com
  • Headquarter Delaware, United States
  • FIGI BBG00RB9BNQ7
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-59.38
Relación precio/flujo de caja
4.43

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
1642
QURE
uniQure N.V. - Ordinary Shares
48.16 USD-1.15%+1.99%+10.28%+195.82%3.34 B USD
1657
GPCR
Structure Therapeutics Inc - American Depositary Shares
45.93 USD-3.04%-6.28%-4.31%+71.77%3.28 B USD
1692
IMNM
Immunome, Inc. - Common Stock
27.19 USD-1.38%-3.65%+19.94%+185.91%3.09 B USD
1699
CLDX
Celldex Therapeutics, Inc. - Common Stock
39.08 USD-0.10%-4.05%+2.60%+43.47%3.07 B USD

Noticias